| Bioactivity | (E)-CHBO4 is a MAO-B inhibitor, with an IC50 of 0.023 μM, and can be used for research on the treatment of Parkinson's disease[1]. | ||||||||||||
| CAS | 126473-61-8 | ||||||||||||
| Formula | C15H10BrFO | ||||||||||||
| Molar Mass | 305.14 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Mohamed A. Abdelgawad, et al. Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease. Journal of Molecular Structure. Volume 1266, 15 October 2022, 133545. |